Blake Borgeson
First SEC filing: April 15, 2021 · Latest: June 4, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 1, 2026 | RXRX | S 10b5-1 | 30,000 | $3.34 | $100,200 | 6,158,287 Direct | -0.48% | Disposed | 23.4% (price as of 2026-10-02) |
| Aug. 4, 2026 | RXRX | S 10b5-1 | 30,000 | $3.25 | $97,500 | 6,188,287 Direct | -0.48% | Disposed | 26.8% (price as of 2026-10-02) |
| July 7, 2026 | RXRX | S 10b5-1 | 40,000 | $3.96 | $158,400 | 6,218,287 Direct | -0.64% | Disposed | 4.0% (price as of 2026-10-02) |
| June 17, 2026 | RXRX | A | 88,424 | · | · | 6,258,287 Direct | +1.43% | Acquired | (price as of 2026-10-02) |
| June 2, 2026 | RXRX | S 10b5-1 | 30,000 | $3.68 | $110,400 | 6,169,863 Direct | -0.48% | Disposed | 12.0% (price as of 2026-10-02) |
| May 5, 2026 | RXRX | S 10b5-1 | 30,000 | $3.52 | $105,600 | 6,199,863 Direct | -0.48% | Disposed | 17.0% (price as of 2026-10-02) |
| April 7, 2026 | RXRX | S 10b5-1 | 30,000 | $3.10 | $93,000 | 6,229,863 Direct | -0.48% | Disposed | 32.9% (price as of 2026-10-02) |
| March 3, 2026 | RXRX | S 10b5-1 | 170,000 | $3.46 | $588,200 | 6,259,863 Direct | -2.64% | Disposed | 19.1% (price as of 2026-10-02) |
| Feb. 3, 2026 | RXRX | S 10b5-1 | 220,000 | $4.20 | $924,000 | 6,429,863 Direct | -3.31% | Disposed | -1.9% (price as of 2026-10-02) |
| Jan. 6, 2026 | RXRX | S 10b5-1 | 220,000 | $4.36 | $959,200 | 6,649,863 Direct | -3.20% | Disposed | -5.5% (price as of 2026-10-02) |
| Dec. 2, 2025 | RXRX | S 10b5-1 | 220,000 | $4.37 | $961,400 | 6,869,863 Direct | -3.10% | Disposed | -5.7% (price as of 2026-10-02) |
| June 18, 2025 | RXRX | A | 22,016 | · | · | 7,089,863 Direct | +0.31% | Acquired | (price as of 2026-10-02) |
| June 18, 2025 | RXRX | A | 44,031 | · | · | 44,031 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2025 | RXRX | A | 1,734 | · | · | 7,067,847 Direct | +0.02% | Acquired | (price as of 2026-10-02) |
| Nov. 12, 2024 | RXRX | S 10b5-1 | 11,447 | $7.64 | $87,455 | 7,066,113 Direct | -0.16% | Disposed | -46.1% (price as of 2026-10-02) |
| Oct. 29, 2024 | RXRX | S 10b5-1 | 11,447 | $6.72 | $76,924 | 7,077,560 Direct | -0.16% | Disposed | -38.7% (price as of 2026-10-02) |
| Oct. 15, 2024 | RXRX | S 10b5-1 | 11,447 | $6.67 | $76,351 | 7,089,007 Direct | -0.16% | Disposed | -38.2% (price as of 2026-10-02) |
| Oct. 1, 2024 | RXRX | A | 2,026 | · | · | 7,100,454 Direct | +0.03% | Acquired | (price as of 2026-10-02) |
| Oct. 1, 2024 | RXRX | S 10b5-1 | 11,447 | $6.22 | $71,200 | 7,098,428 Direct | -0.16% | Disposed | -33.8% (price as of 2026-10-02) |
| Sept. 17, 2024 | RXRX | S 10b5-1 | 11,447 | $6.84 | $78,297 | 7,109,875 Direct | -0.16% | Disposed | -39.8% (price as of 2026-10-02) |
| Sept. 3, 2024 | RXRX | S 10b5-1 | 11,447 | $6.27 | $71,773 | 7,121,322 Direct | -0.16% | Disposed | -34.3% (price as of 2026-10-02) |
| Aug. 20, 2024 | RXRX | S 10b5-1 | 11,447 | $7.12 | $81,503 | 7,132,769 Direct | -0.16% | Disposed | -42.1% (price as of 2026-10-02) |
| Aug. 6, 2024 | RXRX | S 10b5-1 | 11,447 | $6.82 | $78,069 | 7,144,216 Direct | -0.16% | Disposed | -39.6% (price as of 2026-10-02) |
| July 23, 2024 | RXRX | S 10b5-1 | 11,447 | $8.48 | $97,071 | 7,155,663 Direct | -0.16% | Disposed | -51.4% (price as of 2026-10-02) |
| July 9, 2024 | RXRX | S 10b5-1 | 11,447 | $7.32 | $83,792 | 7,167,110 Direct | -0.16% | Disposed | -43.7% (price as of 2026-10-02) |
| July 1, 2024 | RXRX | A | 1,441 | · | · | 7,178,557 Direct | +0.02% | Acquired | (price as of 2026-10-02) |
| June 25, 2024 | RXRX | S 10b5-1 | 11,447 | $9.51 | $108,861 | 7,177,116 Direct | -0.16% | Disposed | -56.7% (price as of 2026-10-02) |
| June 11, 2024 | RXRX | S 10b5-1 | 11,447 | $8.45 | $96,727 | 7,188,563 Direct | -0.16% | Disposed | -51.2% (price as of 2026-10-02) |
| June 3, 2024 | RXRX | A | 13,097 | · | · | 7,200,010 Direct | +0.18% | Acquired | (price as of 2026-10-02) |
| June 3, 2024 | RXRX | A | 26,193 | · | · | 26,193 Direct | · | Acquired | (price as of 2026-10-02) |
| May 28, 2024 | RXRX | S 10b5-1 | 11,447 | $9.17 | $104,969 | 7,186,913 Direct | -0.16% | Disposed | -55.1% (price as of 2026-10-02) |
| May 14, 2024 | RXRX | S 10b5-1 | 20,054 | $10.12 | $202,946 | 7,198,360 Direct | -0.28% | Disposed | -59.3% (price as of 2026-10-02) |
| April 30, 2024 | RXRX | S 10b5-1 | 11,447 | $7.95 | $91,004 | 7,218,414 Direct | -0.16% | Disposed | -48.2% (price as of 2026-10-02) |
| April 16, 2024 | RXRX | S 10b5-1 | 11,447 | $7.66 | $87,684 | 7,229,861 Direct | -0.16% | Disposed | -46.2% (price as of 2026-10-02) |
| April 2, 2024 | RXRX | S 10b5-1 | 11,447 | $8.82 | $100,963 | 7,241,308 Direct | -0.16% | Disposed | -53.3% (price as of 2026-10-02) |
| March 19, 2024 | RXRX | S 10b5-1 | 20,054 | $10.79 | $216,383 | 7,252,755 Direct | -0.28% | Disposed | -61.8% (price as of 2026-10-02) |
| March 5, 2024 | RXRX | S 10b5-1 | 20,054 | $12.06 | $241,851 | 7,272,809 Direct | -0.27% | Disposed | -65.8% (price as of 2026-10-02) |
| Feb. 20, 2024 | RXRX | S 10b5-1 | 309 | $13.04 | $4,029 | 7,292,863 Direct | 0.00% | Disposed | -68.4% (price as of 2026-10-02) |
| Feb. 20, 2024 | RXRX | S 10b5-1 | 19,745 | $12.31 | $243,061 | 7,293,172 Direct | -0.27% | Disposed | -66.5% (price as of 2026-10-02) |
| Feb. 6, 2024 | RXRX | S 10b5-1 | 11,447 | $9.30 | $106,457 | 7,312,917 Direct | -0.16% | Disposed | -55.7% (price as of 2026-10-02) |
| Jan. 23, 2024 | RXRX | S 10b5-1 | 20,054 | $10.58 | $212,171 | 7,324,364 Direct | -0.27% | Disposed | -61.1% (price as of 2026-10-02) |
| Jan. 9, 2024 | RXRX | S 10b5-1 | 13,751 | $13.81 | $189,901 | 7,344,418 Direct | -0.19% | Disposed | -70.2% (price as of 2026-10-02) |
| Jan. 9, 2024 | RXRX | S 10b5-1 | 6,303 | $13.21 | $83,263 | 7,358,169 Direct | -0.09% | Disposed | -68.8% (price as of 2026-10-02) |
| Dec. 26, 2023 | RXRX | S 10b5-1 | 20,054 | $10.63 | $213,174 | 7,364,472 Direct | -0.27% | Disposed | -61.2% (price as of 2026-10-02) |
| Dec. 12, 2023 | RXRX | S 10b5-1 | 11,447 | $7.40 | $84,708 | 7,384,526 Direct | -0.15% | Disposed | -44.3% (price as of 2026-10-02) |
| Nov. 28, 2023 | RXRX | S 10b5-1 | 11,447 | $6.72 | $76,924 | 7,395,973 Direct | -0.15% | Disposed | -38.7% (price as of 2026-10-02) |
| Nov. 14, 2023 | RXRX | S 10b5-1 | 8,885 | $6.32 | $56,153 | 7,407,420 Direct | -0.12% | Disposed | -34.8% (price as of 2026-10-02) |
| Oct. 31, 2023 | RXRX | S 10b5-1 | 8,885 | $5.27 | $46,824 | 7,416,305 Direct | -0.12% | Disposed | -21.8% (price as of 2026-10-02) |
| Oct. 17, 2023 | RXRX | S 10b5-1 | 8,885 | $6.58 | $58,463 | 7,425,190 Direct | -0.12% | Disposed | -37.4% (price as of 2026-10-02) |
| Oct. 3, 2023 | RXRX | S 10b5-1 | 8,885 | $7.29 | $64,772 | 7,434,075 Direct | -0.12% | Disposed | -43.5% (price as of 2026-10-02) |
| Sept. 19, 2023 | RXRX | S 10b5-1 | 8,885 | $8.36 | $74,279 | 7,442,960 Direct | -0.12% | Disposed | -50.7% (price as of 2026-10-02) |
| Sept. 5, 2023 | RXRX | S 10b5-1 | 8,885 | $8.79 | $78,099 | 7,451,845 Direct | -0.12% | Disposed | -53.1% (price as of 2026-10-02) |
| Aug. 22, 2023 | RXRX | S 10b5-1 | 8,885 | $8.91 | $79,165 | 7,460,730 Direct | -0.12% | Disposed | -53.8% (price as of 2026-10-02) |
| Aug. 8, 2023 | RXRX | S 10b5-1 | 3,272 | $11.75 | $38,446 | 7,469,615 Direct | -0.04% | Disposed | -64.9% (price as of 2026-10-02) |
| Aug. 8, 2023 | RXRX | S 10b5-1 | 14,498 | $11.03 | $159,913 | 7,472,887 Direct | -0.19% | Disposed | -62.6% (price as of 2026-10-02) |
| July 25, 2023 | RXRX | S 10b5-1 | 18,719 | $14.61 | $273,485 | 7,487,385 Direct | -0.25% | Disposed | -71.8% (price as of 2026-10-02) |
| July 11, 2023 | RXRX | S 10b5-1 | 8,885 | $6.89 | $61,218 | 7,520,104 Direct | -0.12% | Disposed | -40.2% (price as of 2026-10-02) |
| June 29, 2023 | RXRX | G | 14,000 | · | · | 7,506,104 Direct | -0.19% | Disposed | (price as of 2026-10-02) |
| June 27, 2023 | RXRX | S 10b5-1 | 8,885 | $7.39 | $65,660 | 7,528,989 Direct | -0.12% | Disposed | -44.2% (price as of 2026-10-02) |
| June 16, 2023 | RXRX | A | 25,224 | · | · | 25,224 Direct | · | Acquired | (price as of 2026-10-02) |
| June 16, 2023 | RXRX | A | 12,612 | · | · | 7,537,874 Direct | +0.17% | Acquired | (price as of 2026-10-02) |
| June 13, 2023 | RXRX | S 10b5-1 | 15,485 | $9.98 | $154,540 | 7,525,262 Direct | -0.21% | Disposed | -58.7% (price as of 2026-10-02) |
| May 30, 2023 | RXRX | S 10b5-1 | 8,885 | $8.79 | $78,099 | 7,540,747 Direct | -0.12% | Disposed | -53.1% (price as of 2026-10-02) |
| May 16, 2023 | RXRX | S 10b5-1 | 8,885 | $5.09 | $45,225 | 7,549,632 Direct | -0.12% | Disposed | -19.1% (price as of 2026-10-02) |
| April 18, 2023 | RXRX | S 10b5-1 | 8,885 | $5.93 | $52,688 | 7,558,517 Direct | -0.12% | Disposed | -30.5% (price as of 2026-10-02) |
| April 4, 2023 | RXRX | S 10b5-1 | 8,885 | $6.53 | $58,019 | 7,567,402 Direct | -0.12% | Disposed | -36.9% (price as of 2026-10-02) |
| March 21, 2023 | RXRX | S 10b5-1 | 8,885 | $7.40 | $65,749 | 7,576,287 Direct | -0.12% | Disposed | -44.3% (price as of 2026-10-02) |
| March 7, 2023 | RXRX | S 10b5-1 | 8,885 | $8.33 | $74,012 | 7,585,172 Direct | -0.12% | Disposed | -50.5% (price as of 2026-10-02) |
| Feb. 21, 2023 | RXRX | S 10b5-1 | 8,885 | $7.73 | $68,681 | 7,594,057 Direct | -0.12% | Disposed | -46.7% (price as of 2026-10-02) |
| Feb. 7, 2023 | RXRX | S 10b5-1 | 8,885 | $8.81 | $78,277 | 7,602,942 Direct | -0.12% | Disposed | -53.2% (price as of 2026-10-02) |
| Jan. 24, 2023 | RXRX | S 10b5-1 | 8,885 | $8.71 | $77,388 | 7,611,827 Direct | -0.12% | Disposed | -52.7% (price as of 2026-10-02) |
| Jan. 10, 2023 | RXRX | S 10b5-1 | 8,885 | $7.69 | $68,326 | 7,620,712 Direct | -0.12% | Disposed | -46.4% (price as of 2026-10-02) |
| Jan. 3, 2023 | RXRX | A | 1,325 | · | · | 7,629,597 Direct | +0.02% | Acquired | (price as of 2026-10-02) |
| Dec. 27, 2022 | RXRX | S 10b5-1 | 8,885 | $7.25 | $64,416 | 7,628,272 Direct | -0.12% | Disposed | -43.2% (price as of 2026-10-02) |
| Dec. 13, 2022 | RXRX | S 10b5-1 | 8,885 | $8.96 | $79,610 | 7,637,157 Direct | -0.12% | Disposed | -54.0% (price as of 2026-10-02) |
| Nov. 29, 2022 | RXRX | S 10b5-1 | 8,885 | $8.75 | $77,744 | 7,646,042 Direct | -0.12% | Disposed | -52.9% (price as of 2026-10-02) |
| Nov. 16, 2022 | RXRX | S 10b5-1 | 17,770 | $11.12 | $197,602 | 7,654,927 Direct | -0.23% | Disposed | -62.9% (price as of 2026-10-02) |
| Oct. 3, 2022 | RXRX | A | 920 | · | · | 7,672,697 Direct | +0.01% | Acquired | (price as of 2026-10-02) |
| July 1, 2022 | RXRX | A | 1,186 | · | · | 7,671,777 Direct | +0.02% | Acquired | (price as of 2026-10-02) |
| June 14, 2022 | RXRX | A | 36,290 | · | · | 36,290 Direct | · | Acquired | (price as of 2026-10-02) |
| June 14, 2022 | RXRX | A | 18,145 | · | · | 7,670,591 Direct | +0.24% | Acquired | (price as of 2026-10-02) |
| April 1, 2022 | RXRX | A | 1,300 | · | · | 7,652,446 Direct | +0.02% | Acquired | (price as of 2026-10-02) |
| Jan. 4, 2022 | RXRX | S 10b5-1 | 9,625 | $18.03 | $173,539 | 7,651,146 Direct | -0.13% | Disposed | -77.1% (price as of 2026-10-02) |
| Jan. 3, 2022 | RXRX | A | 555 | · | · | 7,660,771 Direct | +0.01% | Acquired | (price as of 2026-10-02) |
| Dec. 21, 2021 | RXRX | S 10b5-1 | 9,625 | $18.75 | $180,469 | 7,660,216 Direct | -0.13% | Disposed | -78.0% (price as of 2026-10-02) |
| Dec. 7, 2021 | RXRX | S 10b5-1 | 400 | $21.03 | $8,412 | 7,669,841 Direct | -0.01% | Disposed | -80.4% (price as of 2026-10-02) |
| Dec. 7, 2021 | RXRX | S 10b5-1 | 7,725 | $20.38 | $157,436 | 7,670,241 Direct | -0.10% | Disposed | -79.8% (price as of 2026-10-02) |
| Dec. 7, 2021 | RXRX | S 10b5-1 | 1,500 | $19.78 | $29,670 | 7,677,966 Direct | -0.02% | Disposed | -79.2% (price as of 2026-10-02) |
| Nov. 18, 2021 | RXRX | S 10b5-1 | 7,725 | $19.05 | $147,161 | 7,679,466 Direct | -0.10% | Disposed | -78.4% (price as of 2026-10-02) |
| Nov. 18, 2021 | RXRX | S 10b5-1 | 1,900 | $18.32 | $34,808 | 7,687,191 Direct | -0.02% | Disposed | -77.5% (price as of 2026-10-02) |
| Oct. 1, 2021 | RXRX | A | 457 | · | · | 7,689,091 Direct | +0.01% | Acquired | (price as of 2026-10-02) |
| July 1, 2021 | RXRX | A | 278 | · | · | 7,688,634 Direct | 0.00% | Acquired | (price as of 2026-10-02) |
| April 20, 2021 | RXRX | C | 12,500 | · | · | 12,500 Direct | · | Acquired | (price as of 2026-10-02) |
| April 20, 2021 | RXRX | C | 12,500 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 20, 2021 | RXRX | C | 544,743 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 20, 2021 | RXRX | C | 378,309 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 20, 2021 | RXRX | C | 7,688,356 | · | · | 7,688,356 Direct | · | Acquired | (price as of 2026-10-02) |
| April 20, 2021 | RXRX | C | 7,688,356 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 20, 2021 | RXRX | C | 923,052 | · | · | 7,688,356 Direct | +13.64% | Acquired | (price as of 2026-10-02) |
| April 15, 2021 | RXRX | A | 12,500 | · | · | 12,500 Direct | · | Acquired | (price as of 2026-10-02) |
Showing latest 100 of 101 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 18, 2025 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $5.11 | June 18, 2035 | 44,031 | Acquired |
| June 3, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $8.59 | June 3, 2034 | 26,193 | Acquired |
| June 16, 2023 | RXRX | Stock Option (Right to Buy | Class A Common Stock | $8.92 | June 16, 2033 | 25,224 | Acquired |
| June 14, 2022 | RXRX | Stock Option (right to buy) | Class A Common Stock | $6.20 | June 14, 2032 | 36,290 | Acquired |
| April 20, 2021 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $18.00 | April 14, 2031 | 12,500 | Acquired |
| April 20, 2021 | RXRX | Stock Option (Right to Buy) | Common Stock | $18.00 | April 14, 2031 | 12,500 | Disposed |
| April 20, 2021 | RXRX | Series A-1 Preferred Stock | Common Stock | · | · | 544,743 | Disposed |
| April 20, 2021 | RXRX | Series A Preferred Stock | Common Stock | · | · | 378,309 | Disposed |
| April 15, 2021 | RXRX | Stock Option (Right to Buy) | Common Stock [F1] | $18.00 | April 14, 2031 | 12,500 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.